Abstract-Whether NO is involved or not in sustained conduit artery flow-mediated dilatation in humans remains unclear.Moreover, the role of endothelium-derived hyperpolarizing factor (EDHF), synthesized by cytochrome epoxygenases and acting through calcium-activated potassium channels, and its relationship with NO during flow-mediated dilatation have never been investigated previously. In 12 healthy subjects we measured radial artery diameter (echotracking) and blood flow (Doppler) during flow-mediated dilatation induced by gradual distal hand skin heating (34 to 44°C), during the local infusion of saline and inhibitors of NO synthase (N G -monomethyl-L-arginine [L-NMMA]: 8 to 20 mol/min per liter), calcium-activated potassium channels (tetraethylammonium chloride: 9 mol/min per liter), and cytochrome epoxygenases (fluconazole: 0.4 to 1.6 mol/min per liter), alone and in combination. Mean wall shear stress, the flow-mediated dilatation stimulus, was calculated at each level of flow, and the diameter-wall shear stress relationship was constructed. During heating, compared with saline, the diameter-shear stress relationship was shifted downward by L-NMMA, tetraethylammonium, fluconazole, and, in a more pronounced manner, by the combinations of L-NMMA with tetraethylammonium or with fluconazole. Therefore, maximal radial artery flow-mediated dilatation, compared with saline (0.62Ϯ0.03 mm), was decreased under our experimental conditions by L-NMMA (Ϫ39Ϯ4%), tetraethylammonium chloride (Ϫ14Ϯ4%), fluconazole (Ϫ18Ϯ6%), and to a greater extent, by the combinations of L-NMMA with tetraethylammonium (Ϫ64Ϯ4%) or with fluconazole (Ϫ71Ϯ3%). This study demonstrates that NO and a cytochrome-related EDHF are involved in peripheral conduit artery flow-mediated dilatation in humans during sustained flow conditions. Moreover, the synergistic effects of the inhibitors strongly suggest a functional interaction between NO and EDHF pathways. Key Words: conduit arteries Ⅲ endothelium Ⅲ flow-mediated dilatation Ⅲ nitric oxide Ⅲ endothelium-derived hyperpolarizing factor Ⅲ cytochrome P450 C onduit artery flow-mediated dilatation (FMD) is a fundamental mechanism that regulates vascular conductance at rest and during exercise, as well as maintaining wall shear stress within physiological values. Vasodilatation is related to the integrity of the endothelium that releases vasodilatating factors in response to the increase in shear stress. 1 In humans, we 2 and others 3,4 have demonstrated previously the major contribution of NO to peripheral conduit artery FMD in response to reactive hyperemia after a brief period of distal ischemia. This test is currently used in clinical experiments as an index of endothelial function and NO availability. 5,6 However, recent data suggest that, during more sustained hyperemia, conduit artery FMD may occur independently of NO release. [7][8][9] In fact, the local inhibition of NO synthesis by N G -monomethyl-L-arginine (L-NMMA) in healthy subjects did not affect radial artery FMD induced by hand skin heating...
In experimental CHF, long-term allopurinol treatment, initiated in a pathological state of overt CHF, improves LV haemodynamics and function and prevents LV remodelling. These long-term effects are, at least partially, caused by a transient reduction of myocardial ROS shortly after initiation of allopurinol treatment, but whether other mechanism(s), independent of myocardial redox 'status', such as reduced inflammation, are implicated remains to be confirmed.
These data indicate that cocaine administration induces early NADPH-driven O2-. release which may play an important role in the development and progression of the LV dysfunction observed after chronic cocaine abuse.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.